eMed Raises $200M Series A at $2B Valuation

eMed Population Health, a Miami-based healthcare technology company, has raised $200 million in funding at a valuation of more than $2 billion. The financing, announced in March 2026, will support the expansion of its agentic AI platform and a new capitated healthcare model for employers.

Investors

The round was led by Aon Consulting, Inc. and included prominent investors such as Tom Brady, eMed’s Founding Chief Wellness Officer; Jeff Aronin, Founder, Chairman and CEO of Paragon Biosciences; Ara Cohen, Co-Founder and Co-Managing Member of Knighthead Capital Management; Antonio Gracias, Founder and CEO of Valor Equity Partners; Joe Lonsdale, Founder and Managing Partner at 8VC and Co-Founder of Palantir; R.J. Melman, CEO of Lettuce Entertain You Restaurants; Tom Ricketts, Chairman of the Chicago Cubs; and Linda Yaccarino, former CEO of X and current CEO of eMed.

eMed Use of Funds

Proceeds from the financing will be used to further advance the company's agentic AI platform and strengthen the balance sheet to support a new capitated model designed to help employers manage healthcare costs.

About eMed

Led by CEO Linda Yaccarino, eMed Population Health is a healthcare technology company focused on clinically supervised GLP-1/GIP management and population health programs for employers. The company provides a platform designed to support patients throughout their treatment journey, with a focus on medication adherence, clinical outcomes, and measurable improvements in health.

Funding Details

Company Website: https://emed.com

Company: eMed
Raised: $200M
Round: Series A
Funding Date: March 26, 2026
Lead Investor: AON Consulting, Inc.
Additional Investors: Tom Brady, Jeff Aronin, Ara Cohen, Antonio Gracias, Joe Lonsdale, R.J. Melman, Tom Ricketts, Linda Yaccarino
Software Category: Health Technology
Source: https://www.prnewswire.com/news-releases/emed-raises-200-million-at-2-billion-plus-valuation-302725381.html